Oxidative stress plays a critical role in the immune defense by killing pathogens and tumor cells, but this form of stress also can promote disease processes (1) . The vast number of oxidation products and their potential targets has made it difficult to identify the critical biological bases of such pathogenic mechanisms. Our previous work showed that a potent oxidant known as "peroxynitrite" (ONOO − ) activates distinct celldeath pathways in motor neurons and in PC12 cells, a cell line used to study neural cell growth and differentiation (1, 2) . Oxidative damage to proteins by ONOO − can be detected by examining the addition of nitro groups to tyrosine residues. This process is not random and occurs at specific sites on surprisingly few proteins (3) . Because cell death induced by ONOO − in motor neurons and PC12 cells can be prevented by small molecules that avert tyrosine nitration (4), we hypothesized that nitration of a particular protein might activate specific death-signaling pathways. The challenge has been to distinguish the nitrated proteins that act as causal drivers of pathology from the far more common sites of protein nitration that may constitute collateral damage with minimal functional consequences.
Mass spectrometry revealed that the prosurvival protein heat shock protein 90 (Hsp90) is a major target for ONOO − in vivo and that five of its 26 tyrosine residues are susceptible to nitration. Neuronal death was triggered by the intracellular delivery of purified Hsp90 treated with ONOO − . Even without induction, constitutive Hsp90 expression accounts for ∼3% of soluble protein in motor neurons. Delivery of only ∼4% of nitrated Hsp90 relative to endogenous, unmodified Hsp90 was sufficient to induce motor neuron death, indicating that nitration of Hsp90 elicits a gain of function that turns the protein from prosurvival to toxic. The replacement of the five tyrosine residues susceptible to nitration by ONOO − to nitration-resistant phenylalanine residues prevented recombinant Hsp90 from becoming toxic after treatment with ONOO − . Retention of either tyrosine residues 33 or 56 allowed this mutated form of Hsp90 to become toxic after treatment with ONOO − , whereas tyrosine at the other three sites did not affect toxicity.
These results were supported further by using site-specific unnatural amino acid mutagenesis to incorporate a nitrotyrosine residue rather than a tyrosine residue directly at each of the five known sites of nitration in Hsp90; only nitrotyrosine incorporated at either position 33 or 56 on Hsp90 induced motor neuron death. Thus, incorporation of a single nitrotyrosine near the ATP-binding pocket of the protein was sufficient to induce motor neuron death at the same levels observed for the ONOO − -treated recombinant Hsp90 protein.
Further study revealed that the toxic form of nitrated Hsp90 was present in motor neurons of spinal cords from sporadic amyotrophic lateral sclerosis (ALS) patients, in animal models of ALS, and in spinal cords following experimental spinal cord contusion. These results show that nitration of Hsp90 occurs in vivo in the cells and tissues most affected by chronic degenerative diseases like ALS as well as after acute trauma to the central nervous system. Furthermore, we were able to show that nitration of Hsp90 induced motor neuron death by affecting P2X7-mediated activation of the Fas death pathway (Fig. P1) . P2X7 is an extracellular ATP receptor/channel implicated in inflammation and cell death, and the binding of Hsp90 to its intracellular domain regulates P2X7 activity. Inhibitors of P2X7, the Fas pathway, and caspases-proteins that, when activated, are a hallmark of cell death by a process known as apoptosis-all prevented motor neuron death induced by nitrated Hsp90. In these cells, the activation of P2X7 resulted in a calcium influx that mobilized Fas ligand (FasL) from intracellular vesicles to the plasma membrane. Remarkably, the cell-death pathway that was activated by nitrated Hsp90 is the same pathway triggered by the expression of mutant superoxide dismutase (SOD), an antioxidant enzyme that, when mutated, is linked to familial ALS (5).
The approach used here provides conclusive evidence that selective nitration at a specific tyrosine residue converts Hsp90 from a prosurvival protein into a potent mediator of neuronal cell death. The high cellular abundance of Hsp90 makes it a potential sensor for ONOO KCl, 1 M NaC, pH 7.4), the absorbed proteins were eluted with a linear gradient of 25-100% buffer B. Fractions were collected and analyzed by SDS/PAGE. Fractions containing the highest heat-shock protein 90 (Hsp90) concentration were pooled and dialyzed against 10 mM dialysis buffer (pH 6.8). The pooled Hsp90 fractions were loaded on a hydroxyapatite column (BioRad) equilibrated with 10 mM KH 2 PO 4 (pH 6.8). After washing with 10 mM KH 2 PO 4 (pH 6.8), proteins were eluted with a linear gradient of 10-400 mM KH 2 PO 4 (pH 6.8) buffer. Fractions were collected and analyzed by SDS/PAGE. Fractions containing the highest Hsp90 concentration were pooled. The pooled fractions were dialyzed against 50 mM Tris, 2.5 mM MgCl 2 , 2.5 mM KH 2 PO 4 , 25 mM KCl, 2 mM DTT, 0.5 mM PMSF, pH 7.4. The protein concentrations were adjusted to 5 mg/mL using Centricon Plus-20 (Millipore). Hsp90 was purified further by gel filtration using a Superdex 200 HiLoad16/60 column (Amersham Biosciences). The column was equilibrated with 50 mM Tris, 2.5 mM MgCl 2 , 150 mM KCl, KH 2 PO 4 , pH 7.4. Fractions were collected and analyzed with SDS/PAGE. . Amino acid sequence alignment of yeast 82-kDa heat-shock protein (Hsp82) and rat and human Hsp90α and -β and confirmation of the site-specific incorporation of nitrotyrosine residues into human Hsp90β. (A) The amino acid sequences corresponding to yeast Hsp82 and rat and human Hsp90α and -β were aligned using the Multiple Sequence Alignment (MSA) tool from the Expert Protein Analysis System (ExPASy) Proteomics Server. The asterisks denote the position of the five tyrosine residues prone to nitration (in red). Of note are the regions with a high degree of homology surrounding the tyrosine residues of interest and the high degree of homology between the human and rat Hsp90 sequences. (B-F) To confirm the site-specific incorporation of nitrotyrosine into recombinant human Hsp90β, in-gel digests were performed on pure proteins with trypsin or gluC, and the resulting fragments were analyzed by tandem mass spectrometry (MS/MS) fragmentation in two independent facilities. Shown are spectra of the sequence-specific MS/MS fragmentation of each peptide containing nitrotyrosine for each of the genetically nitrated Hsp90 proteins. A through E show spectra of relevant peptides from digests of nitrotyrosine at sites 33, 56, 276, 484, and 596, respectively. (G) Table showing the digest method and expected fragments detected for A-E with the altered site labeled as 3NT (in red). These spectra confirm 3-nitrotryosine incorporation at the expected positions. (A and B) The p38 inhibitor SB253580 (1 μM) (A), and the NOS inhibitor L-NG-nitroarginine methyl ester (L-NAME) (100 μM) (B) did not protect motor neurons from nitrated Hsp90-induced cell death. The motor neurons were incubated with SB253580 and L-NAME for 24 h after intracellular delivery of peroxynitrite-treated Hsp90. *P < 0.05 versus WT, **P < 0.05 versus WT + ONOO The peptides were transferred to a membrane using a Slot blot device (Bio-Rad) as identified by the legend on the left, and were incubated with a monoclonal antibody (1:2,000 dilution) raised to recognize nitrated Hsp90. The primary antibody then was visualized using the Odyssey system (Licor) after incubation with a corresponding infrared fluorescent secondary antibody. The antibody recognized only peroxynitrite-treated Hsp90 and the peptide 2B corresponding to tyrosine 56 in Hsp90β. (C) The specificity of the antibody was corroborated by Western blot. The myc-tagged recombinant Hsp90β treated or not treated with peroxynitrite (WT + ONOO − and WT, respectively) and the five modified proteins containing a single nitrotyrosine in the positions prone to nitration (3NT) were loaded into a SDS/PAGE. A polyclonal antibody for the myc tag was used to detect total Hsp90β, and the monoclonal antibody was used to detect nitrated Hsp90. "Merge" shows the superposition of both signals. These results show that the antibody against nitrated Hsp90 and used for immunohistochemistry in Fig. 4 recognized only Hsp90 with nitrotyrosine in position 56.
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Elvehjem-Potter in homogenization buffer (50 mM Tris, 0.25 M sucrose, 25 mM KCl, 5 mM MgCl 2 , 3.3 mM CaCl 2 , 0.5 mM PMSF, pH 7.4). The homogenate was centrifuged for 15 min at 1,500 × g at 4°C. The supernatant was spun for 1 h at 10,000 × g at 4°C. Floating fat was removed carefully, and the clear cytosol was dialyzed against dialysis buffer (50 mM Tris, 2.5 mM MgCl 2 , 2.5 mM KH 2 PO 4 , 25 mM KCl, 2 mM DTT, 0.5 mM PMSF, pH 7.4). After dialysis, the cytosol was centrifuged at 95,000 × g at 4°C for 14 h. Floating fat was removed carefully. The supernatant was collected and filtered with a 0.45-μm filter. The cytosolic fraction was loaded on an ion exchange column (
